Fredric N Eshelman - Net Worth and Insider Trading
Fredric N Eshelman Net Worth
The estimated net worth of Fredric N Eshelman is at least $202 Million dollars as of 2024-11-29. Fredric N Eshelman is the Executive Chairman of The Medicines Co and owns about 2,072,920 shares of The Medicines Co (MDCO) stock worth over $176 Million. Fredric N Eshelman is the Director, 10% Owner of G1 Therapeutics Inc and owns about 3,689,151 shares of G1 Therapeutics Inc (GTHX) stock worth over $26 Million. Fredric N Eshelman is also the Director, 10% Owner of Eyenovia Inc and owns about 1,273,428 shares of Eyenovia Inc (EYEN) stock worth over $118,301. Details can be seen in Fredric N Eshelman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Fredric N Eshelman has not made any transactions after 2018-01-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Fredric N Eshelman
Fredric N Eshelman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Fredric N Eshelman owns 8 companies in total, including Aravive Inc (ARAV) , Eyenovia Inc (EYEN) , and Liquidia Corp (LQDA) among others .
Click here to see the complete history of Fredric N Eshelman’s form 4 insider trades.
Insider Ownership Summary of Fredric N Eshelman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARAV | Aravive Inc | 2020-04-08 | director |
EYEN | Eyenovia Inc | 2020-09-11 | director |
LQDA | Liquidia Corp | 2020-11-19 | 10 percent owner |
2017-11-13 | director & 10 percent owner | ||
2019-11-19 | director | ||
2018-05-31 | director & Executive Chairman | ||
2016-03-08 | director | ||
2019-11-19 | director |
Fredric N Eshelman Latest Holdings Summary
Fredric N Eshelman currently owns a total of 3 stocks. Among these stocks, Fredric N Eshelman owns 2,072,920 shares of The Medicines Co (MDCO) as of December 8, 2017, with a value of $176 Million and a weighting of 86.91%. Fredric N Eshelman owns 3,689,151 shares of G1 Therapeutics Inc (GTHX) as of November 13, 2017, with a value of $26 Million and a weighting of 13.03%. Fredric N Eshelman also owns 1,273,428 shares of Eyenovia Inc (EYEN) as of January 29, 2018, with a value of $118,301 and a weighting of 0.06%.
Latest Holdings of Fredric N Eshelman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MDCO | The Medicines Co | 2017-12-08 | 2,072,920 | 84.90 | 175,990,908 |
GTHX | G1 Therapeutics Inc | 2017-11-13 | 3,689,151 | 7.15 | 26,377,430 |
EYEN | Eyenovia Inc | 2018-01-29 | 1,273,428 | 0.09 | 118,301 |
Holding Weightings of Fredric N Eshelman
Fredric N Eshelman Form 4 Trading Tracker
According to the SEC Form 4 filings, Fredric N Eshelman has made a total of 0 transactions in The Medicines Co (MDCO) over the past 5 years. The most-recent trade in The Medicines Co is the acquisition of 200,000 shares on December 8, 2017, which cost Fredric N Eshelman around $5 Million.
According to the SEC Form 4 filings, Fredric N Eshelman has made a total of 0 transactions in G1 Therapeutics Inc (GTHX) over the past 5 years. The most-recent trade in G1 Therapeutics Inc is the acquisition of 250,000 shares on November 13, 2017, which cost Fredric N Eshelman around $5 Million.
According to the SEC Form 4 filings, Fredric N Eshelman has made a total of 0 transactions in Eyenovia Inc (EYEN) over the past 5 years. The most-recent trade in Eyenovia Inc is the acquisition of 335,000 shares on January 29, 2018, which cost Fredric N Eshelman around $3 Million.
Insider Trading History of Fredric N Eshelman
- 1
Fredric N Eshelman Trading Performance
GuruFocus tracks the stock performance after each of Fredric N Eshelman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Fredric N Eshelman is 13.74%. GuruFocus also compares Fredric N Eshelman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Fredric N Eshelman within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Fredric N Eshelman's insider trading performs compared to the benchmark.
Performance of Fredric N Eshelman
Fredric N Eshelman Ownership Network
Fredric N Eshelman Owned Company Details
What does Aravive Inc do?
Who are the key executives at Aravive Inc?
Fredric N Eshelman is the director of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .
Aravive Inc (ARAV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aravive Inc Insider Transactions
Fredric N Eshelman Mailing Address
Above is the net worth, insider trading, and ownership report for Fredric N Eshelman. You might contact Fredric N Eshelman via mailing address: Ppd Inc, 929 North Front Street, Wilmington Nc 28401.